Paper38540356
Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia.
Tada H and 5 others. Genes (Basel), 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Genetic Counseling and Genetic Testing for Familial Hypercholesterolemia. Papers, record 38540356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38540356
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperlipoproteinemia Type II | Major topic |
| Coronary Artery Disease | Major topic |
| Humans | |
| Cholesterol, LDL | |
| Genetic Counseling | |
| Genetic Testing |
Source PubMed
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38299163 | Putative Pathogenic Variants of ABCG5 and ABCG8 of Sitosterolemia in Patients With Hyper-Low-Density Lipoprotein Cholesterolemia. | J Lipid Atheroscler | 2024 | https://conductscience.org/library/papers/38299163 | PubMed |
| 2 | 33020668 | Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. | Nat Genet | 2020 | https://conductscience.org/library/papers/33020668 | PubMed |
| 3 | 32039990 | Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. | Curr Opin Lipidol | 2020 | https://conductscience.org/library/papers/32039990 | PubMed |
| 4 | 38155796 | Clinical Characteristics of Homozygous Familial Hypercholesterolemia in Japan: A Survey Using a National Database. | JACC Asia | 2023 | https://conductscience.org/library/papers/38155796 | PubMed |
| 5 | 32439005 | Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. | J Am Coll Cardiol | 2020 | https://conductscience.org/library/papers/32439005 | PubMed |
| 6 | 37793753 | Childhood Screening for Familial Hypercholesterolemia: JACC Review Topic of the Week. | J Am Coll Cardiol | 2023 | https://conductscience.org/library/papers/37793753 | PubMed |
| 7 | 37739193 | Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/Cas9 constructs. | Gene | 2024 | https://conductscience.org/library/papers/37739193 | PubMed |
| 8 | 37371118 | A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD. | Cells | 2023 | https://conductscience.org/library/papers/37371118 | PubMed |
| 9 | 35480308 | Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia. | Front Genet | 2022 | https://conductscience.org/library/papers/35480308 | PubMed |
| 10 | 37322181 | International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. | Nat Rev Cardiol | 2023 | https://conductscience.org/library/papers/37322181 | PubMed |
| 11 | 34711342 | Familial Hypercholesterolemia: JACC Focus Seminar 4/4. | J Am Coll Cardiol | 2021 | https://conductscience.org/library/papers/34711342 | PubMed |
| 12 | 37436769 | Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome. | JAMA Cardiol | 2023 | https://conductscience.org/library/papers/37436769 | PubMed |
| 13 | 35442238 | Long-Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency. | J Pediatr Gastroenterol Nutr | 2022 | https://conductscience.org/library/papers/35442238 | PubMed |
| 14 | 29233637 | Compound heterozygous familial hypercholesterolemia in a Chinese boy with a de novo and transmitted low-density lipoprotein receptor mutation. | J Clin Lipidol | 2018 | https://conductscience.org/library/papers/29233637 | PubMed |
| 15 | 37769168 | Predictors of cardiovascular risk in familial hypercholesterolemia. | Curr Opin Lipidol | 2023 | https://conductscience.org/library/papers/37769168 | PubMed |
| 16 | 38031840 | Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia. | Arterioscler Thromb Vasc Biol | 2024 | https://conductscience.org/library/papers/38031840 | PubMed |
| 17 | 34698927 | Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors. | Curr Atheroscler Rep | 2021 | https://conductscience.org/library/papers/34698927 | PubMed |
| 18 | 34687802 | LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments. | Int J Cardiol | 2021 | https://conductscience.org/library/papers/34687802 | PubMed |
| 19 | 37847331 | Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies. | Curr Atheroscler Rep | 2023 | https://conductscience.org/library/papers/37847331 | PubMed |
| 20 | 7841735 | Sonography in the detection of achilles tendon xanthomata in children with familial hypercholesterolaemia. | Acta Paediatr | 1994 | https://conductscience.org/library/papers/7841735 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42774604 | Association between serum lipoprotein(a) levels and aortic vulnerable plaques assessed by non-obstructive general angioscopy. | Atheroscler Plus | 2026 | https://conductscience.org/library/papers/42774604 | PubMed |
| 42195352 | The Role of Next-Generation Sequencing in Cardiovascular Disease: A New Era of Precision Cardiology. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42195352 | PubMed |
| 41605678 | The Mysterious Question on Discordance between Achilles Tendon Thickness Assessed by Ultrasound and X-ray Has been Solved. | J Atheroscler Thromb | 2026 | https://conductscience.org/library/papers/41605678 | PubMed |
| 41182226 | Significance of Clinical and Genetic Signatures of Familial Hypercholesterolemia Among Patients With Severe Hypercholesterolemia. | JACC Adv | 2025 | https://conductscience.org/library/papers/41182226 | PubMed |
| 40944193 | Personalized Nutrition Biomarkers and Dietary Strategies for Atherosclerosis Risk Management: A Systematic Review. | Nutrients | 2025 | https://conductscience.org/library/papers/40944193 | PubMed |
| 40908092 | Subclassification of Phenotypic Homozygous Familial Hypercholesterolemia. | JACC Asia | 2025 | https://conductscience.org/library/papers/40908092 | PubMed |
| 40516942 | Prevalence of very high cholesterol levels in asymptomatic military recruits: A single center study. | Saudi Med J | 2025 | https://conductscience.org/library/papers/40516942 | PubMed |
| 39459389 | The Importance of Genetic Testing for Familial Hypercholesterolemia: A Pediatric Pilot Study. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39459389 | PubMed |
| 39202032 | Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling. | J Pers Med | 2024 | https://conductscience.org/library/papers/39202032 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38540356
GET https://conductscience.org/api/papers/v1/38540356/references?page=2